US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Panbela Therapeutics Inc (PBLA)
Panbela Therapeutics Inc (PBLA) ニュース

PBLA

Panbela Therapeutics (PBLA)

Panbela Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PBLA

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/24	21 : 00	GlobeNewswire Inc.	First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/08/17	06 : 25	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/08/14	05 : 10	GlobeNewswire Inc.	Panbela Provides Business Update and Reports Q2 2024 Financial Results	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/07/31	06 : 30	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/07/31	05 : 59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/07/04	05 : 46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/06/24	21 : 00	GlobeNewswire Inc.	Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/06/10	21 : 00	GlobeNewswire Inc.	Panbela Announces Oral Presentation at Digestive Disease Week (DDW):	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/05/29	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/05/16	05 : 10	GlobeNewswire Inc.	Panbela Provides Business Update and Reports Q1 2024 Financial Results	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/05/06	21 : 00	GlobeNewswire Inc.	Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/05/02	05 : 15	GlobeNewswire Inc.	Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/30	21 : 00	GlobeNewswire Inc.	Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/27	05 : 39	Edgar (US Regulatory)	Form PRER14A - Preliminary Proxy Soliciting materials	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/26	05 : 36	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/26	05 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/25	22 : 09	Edgar (US Regulatory)	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/22	21 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/22	21 : 00	GlobeNewswire Inc.	Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/19	05 : 31	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/18	21 : 00	GlobeNewswire Inc.	Panbela Announces Poster Presentation at American Association for Cancer Research:	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/17	21 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/17	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/17	06 : 29	GlobeNewswire Inc.	Panbela Announces Transfer to OTCQB Market	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/05	05 : 17	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/03	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/30	06 : 24	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/30	06 : 08	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/27	05 : 15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/27	05 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:PBLA

1 2 3 4 5 6 7 8 9 次へ >>

BNP Paribas Issuance

BNP Paribas Issuance

Btsp Ii Fundo De Investi...

Be Shaping the Future

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約